Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@biotechsanya2 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1715091835259887616.png) @biotechsanya2 SSV

SSV posts on X about $traw, $5byear, $15mil, $ifrx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1715091835259887616/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1715091835259887616/c:line/m:interactions.svg)

- X Week XXXXX +2%
- X Month XXXXX +2,675%
- X Months XXXXX +9,792%
- X Year XXXXX +943%

### Mentions: X [#](/creator/twitter::1715091835259887616/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1715091835259887616/c:line/m:posts_active.svg)

- X Week X +350%
- X Month XX +1,200%
- X Months XX +850%
- X Year XX +950%

### Followers: XXX [#](/creator/twitter::1715091835259887616/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1715091835259887616/c:line/m:followers.svg)

- X Week XXX +24%
- X Month XXX +152%
- X Months XXX +739%

### CreatorRank: undefined [#](/creator/twitter::1715091835259887616/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1715091835259887616/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1715091835259887616/influence)
---

**Social category influence**
[currencies](/list/currencies)  XX% [finance](/list/finance)  XX%

**Social topic influence**
[$traw](/topic/$traw) 10%, [$5byear](/topic/$5byear) 10%, [$15mil](/topic/$15mil) 10%, [$ifrx](/topic/$ifrx) XX%

**Top accounts mentioned or mentioned by**
[@balabioresearch](/creator/undefined) [@streetcred2017](/creator/undefined) [@jeremyfalmouth](/creator/undefined) [@osprey172](/creator/undefined) [@biohazard3737](/creator/undefined) [@seedy19tron](/creator/undefined) [@kiefchief69](/creator/undefined) [@crocsanalyst](/creator/undefined) [@se19edy](/creator/undefined)
### Top Social Posts [#](/creator/twitter::1715091835259887616/posts)
---
Top posts by engagements in the last XX hours

"$TRAW seems like an obvious play at these levels: Binary P2a readout for TRX01 which has a $5b/year TAM in Covid-19 mcap at $15mil and strong PK data from P1. Target: $1326 if P2 is successful; also is a wonderful run-up play. Will publish full report soon on Substack. If they fail this likely goes to $XXXX Disclosure: Im long TRAW; no compensation; opinion only; see bio"  
[X Link](https://x.com/biotechsanya2/status/1975652886093635967) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-07T20:02Z XXX followers, 3818 engagements


"$IFRX-- I *think* the main question is: did Avacopan fail because of insufficient blockade on of C5aR OR because C5aR s not rate-limiting If INF904 is a *better* Avacopan it DOESN'T matter if the reason why Ava' failed is that C5aR blockade doesn't achieve anything due to TNF-a signalling; other "Ils" is what drives signalling-- if the case is that C5aR blockade (IFRX thinks they have a more potent Ava') IS sufficient this COULD be a win. I think the odds of this working are minimal as we know that X C5a inhibitors have already failed that being said there's a small chance this hits as this"  
[X Link](https://x.com/biotechsanya2/status/1978587133511184878) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-15T22:21Z XXX followers, XXX engagements


"@StreetCred2017 Yes I am referring to Avas failed HS trial. Also interesting they have never tested this in CSU despite sort of similar ideation therein and pathways etc"  
[X Link](https://x.com/biotechsanya2/status/1978589768918200775) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-15T22:32Z XXX followers, XXX engagements


"@seedy19tron @KiefChief69 @CrocsAnalyst seedy is nktr a buyout candidate can you remind me pls also do they have a differentiated MoA Not sure about these parts. thx"  
[X Link](https://x.com/biotechsanya2/status/1980099579761524768) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-20T02:31Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@biotechsanya2 Avatar @biotechsanya2 SSV

SSV posts on X about $traw, $5byear, $15mil, $ifrx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX +2%
  • X Month XXXXX +2,675%
  • X Months XXXXX +9,792%
  • X Year XXXXX +943%

Mentions: X #

Mentions Line Chart

  • X Week X +350%
  • X Month XX +1,200%
  • X Months XX +850%
  • X Year XX +950%

Followers: XXX #

Followers Line Chart

  • X Week XXX +24%
  • X Month XXX +152%
  • X Months XXX +739%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence currencies XX% finance XX%

Social topic influence $traw 10%, $5byear 10%, $15mil 10%, $ifrx XX%

Top accounts mentioned or mentioned by @balabioresearch @streetcred2017 @jeremyfalmouth @osprey172 @biohazard3737 @seedy19tron @kiefchief69 @crocsanalyst @se19edy

Top Social Posts #


Top posts by engagements in the last XX hours

"$TRAW seems like an obvious play at these levels: Binary P2a readout for TRX01 which has a $5b/year TAM in Covid-19 mcap at $15mil and strong PK data from P1. Target: $1326 if P2 is successful; also is a wonderful run-up play. Will publish full report soon on Substack. If they fail this likely goes to $XXXX Disclosure: Im long TRAW; no compensation; opinion only; see bio"
X Link @biotechsanya2 2025-10-07T20:02Z XXX followers, 3818 engagements

"$IFRX-- I think the main question is: did Avacopan fail because of insufficient blockade on of C5aR OR because C5aR s not rate-limiting If INF904 is a better Avacopan it DOESN'T matter if the reason why Ava' failed is that C5aR blockade doesn't achieve anything due to TNF-a signalling; other "Ils" is what drives signalling-- if the case is that C5aR blockade (IFRX thinks they have a more potent Ava') IS sufficient this COULD be a win. I think the odds of this working are minimal as we know that X C5a inhibitors have already failed that being said there's a small chance this hits as this"
X Link @biotechsanya2 2025-10-15T22:21Z XXX followers, XXX engagements

"@StreetCred2017 Yes I am referring to Avas failed HS trial. Also interesting they have never tested this in CSU despite sort of similar ideation therein and pathways etc"
X Link @biotechsanya2 2025-10-15T22:32Z XXX followers, XXX engagements

"@seedy19tron @KiefChief69 @CrocsAnalyst seedy is nktr a buyout candidate can you remind me pls also do they have a differentiated MoA Not sure about these parts. thx"
X Link @biotechsanya2 2025-10-20T02:31Z XXX followers, XXX engagements

@biotechsanya2
/creator/twitter::biotechsanya2